Keyword

lenalidomide

Description: Lenalidomide is an immunomodulatory anticancer drug used primarily to treat multiple myeloma and certain other blood cancers.

Primary topic: Multiple Myeloma Research and Treatments (53%)

Wikidata ID: wiki/Q425681

OpenAlex ID: keywords/lenalidomide

Multiple Myeloma

2011 · Antonio Palumbo, Kenneth Anderson · New England Journal of Medicine · 2,336

Improved survival in multiple myeloma and the impact of novel therapies

2007 · Shaji K. Kumar, S. Vincent Rajkumar, et al. · Blood · 2,241

PDF

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

2013 · Jan Krönke, Namrata D. Udeshi, et al. · Science · 1,851

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

2013 · Gang Lu, Richard E. Middleton, et al. · Science · 1,564

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

2007 · Meletios Dimopoulos, Andrew Spencer, et al. · New England Journal of Medicine · 1,453

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

2016 · Meletios A. Dimopoulos, Albert Oriol, et al. · New England Journal of Medicine · 1,444

PDF

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

2014 · A. Keith Stewart, S. Vincent Rajkumar, et al. · New England Journal of Medicine · 1,334

PDF

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

2015 · Sagar Lonial, Meletios Dimopoulos, et al. · New England Journal of Medicine · 1,324

PDF

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

2006 · Alan List, Gordon Dewald, et al. · New England Journal of Medicine · 1,324

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

2017 · Michel Attal, Valerie Lauwers-Cances, et al. · New England Journal of Medicine · 1,253

PDF

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

2007 · Donna M. Weber, Christine Chen, et al. · New England Journal of Medicine · 1,237

PDF

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

2013 · María-Victoria Mateos, Miguel-Teodoro Hernández, et al. · New England Journal of Medicine · 1,171

PDF

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

2012 · Michel Attal, Valerie Lauwers-Cances, et al. · New England Journal of Medicine · 1,158

PDF

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

2012 · Philip L. McCarthy, Kouros Owzar, et al. · New England Journal of Medicine · 1,151

PDF

Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide

2014 · Eric S. Fischer, Kerstin Böhm, et al. · Nature · 1,105

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

2016 · Philippe Moreau, Tamás Masszi, et al. · New England Journal of Medicine · 1,060

PDF

Diagnosis and Management of Multiple Myeloma

2022 · Andrew J. Cowan, Damian J. Green, et al. · JAMA · 1,033

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

2019 · Thierry Facon, Shaji Kumar, et al. · New England Journal of Medicine · 1,017

PDF

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

2019 · Philippe Moreau, Michel Attal, et al. · The Lancet · 968

PDF

American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

2007 · Gary H. Lyman, Alok A. Khorana, et al. · Journal of Clinical Oncology · 952

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

2009 · S Vincent Rajkumar, Susanna Jacobus, et al. · The Lancet Oncology · 935

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

2016 · Pieter Sonneveld, Hervé Avet-Loiseau, et al. · Blood · 929

PDF

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

2019 · Sagar Lonial, Susanna Jacobus, et al. · Journal of Clinical Oncology · 908

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

2016 · Brian G M Durie, Antje Hoering, et al. · The Lancet · 908

Efficacy of Lenalidomide in Myelodysplastic Syndromes

2005 · Alan List, Sandy Kurtin, et al. · New England Journal of Medicine · 882

PDF

Works count: 17,660

Citation count: 256,200